Anavex Life Sciences Corp (AVXL)

[blu_1]

What would you consider positive 41 weeks results: improvement from baseline, stabilization, slight decrease of scores, moderate decrease? For me, positive scores, given subtherapeutic dosings and the adverse affect of donepezil, would be: moderate drop in scores for the 273+donepezil group and slight decrease in scores for the 273 monotherapy group. Maybe a moderate decrease in scores would be OK for this group too. Very good and unexpected results, imo, would be stabilization of scores for the 273 monotherapy subjects. I'd like to see full results for the 273 monotherapy group.